Malaysia
Search
Sign In
Change Password
Points
Sign Out
Top Medical News
In patients with atrial fibrillation (AF), treatment with direct oral anticoagulants (DOACs) appear to reduce the risk of intracranial haemorrhage (ICH) and all-cause mortality in women only, a recent study has found. Additionally, the association of lower ICH risk persists when compared with warfarin users with good anticoagulation control.
Variations in albuminuria predict changes in renal risk among patients with hypertension and type 2 diabetes (T2D) under real-life clinical conditions, reports a study, suggesting that albuminuria status may help optimize therapeutic strategy.
Higher total intake of dairy products, especially yogurt, may help reduce the risk of incident hypertension in middle-aged and older adult men and women, suggests a recent study.
Cigarette smoking appears to increase the risk of atrial fibrillation in a dose-dependent manner, though the effect is weaker among former smokers, according to a recent meta-analysis.
Diabetic patients in a decompensated state and who develop type 2 myocardial infarction (MI) have an increased risk for mortality and major adverse cardiac events (MACE), according to a new study. In addition, these patients are potentially at risk for undiagnosed coronary artery disease.
New drug applications approved by US FDA as of 1 - 15 July 2018 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Pulmonary vein isolation delivers ionizing radiation doses comparable to, or lower than, other fluoroscopy-guided cardiac procedures despite prolonged procedure times, according to a recent study.
Special Reports
At the recent ‘Reinforced for the Glycaemic Challenge’ symposium held at Shangri-la Hotel, Kuala Lumpur, Associate Professor Dr Alexander Tan, Professor Dr Chee Kok Han and Dr Chan Siew Pheng shared their insights into the importance of achieving glycaemic control in patients with type 2 diabetes mellitus (T2DM), while simultaneously providing them with cardiovascular protection.
CoQ10 isn't as popular as vitamin C or B in our daily lives but it's time to have a closer look at this vital nutrient.
In this issue of MIMS Cardiology Supplement, we bring you clinical updates related to combating hypercholesterolaemia, highlighting the role of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in lowering low-density lipoprotein-cholesterol levels.
Home blood pressure monitoring (HBPM) is increasingly being recognized as an accurate adjunct to clinic blood pressure measurement for the diagnosis and management of hypertension. We discussed the HOPE Asia Network’s recently published consensus recommendations on HBPM with lead author, Prof. Sungha Park.
Click here to view the interview video with one of the authors - Professor Sungha Park
Click here to view the interview video with one of the authors - Professor Sungha Park
In an effort to better understand hypertension subtypes – including morning and white-coat hypertension – in Asian patients, the HOPE Asia Network has initiated the Asia BP@Home study across 12 countries and regions. We discussed the study’s design and objectives with lead investigator, Prof. Kazuomi Kario.
Click here to view the interview video with lead investigator - Professor Kazuomi Kario
Click here to view the interview video with lead investigator - Professor Kazuomi Kario
At a cardiology conference held in Hilton Kuala Lumpur, senior consultant cardiologist Dato’ Sri Dr Azhari Rosman spoke on the importance of non–high-density lipoprotein cholesterol (non–HDL-C) and combination therapy as a novel approach in the management of atherogenic dyslipidemia (AD).
Through a cardiology webcast hosted by Pfizer, Dr Jeyamalar Rajadurai, Dr Salim Virani and Dr Pamela Morris shared their insights into the importance of primary prevention measures in reducing the burden of atherosclerotic cardiovascular disease (ASCVD).
Conference Reports
The 2018 European Society of Cardiology and European Society of Hypertension (ESC/ESH) hypertension guideline, which is slated for full release at the ESC Congress in August, maintains the 2013 classification system based on blood pressure (BP) levels yet extends drug therapy to more patient groups, with combination therapy as the first-step treatment strategy recommended for most patients with hypertension, says a renowned cardiologist.
The trend of cardiovascular (CV) events among patients with type 2 diabetes (T2D) in Taiwan declined consistently except for myocardial infarction (MI), which had increasing prevalence and incidence rates, according to a 10-year outline of CV disease patterns in T2D presented at APSC 2018.
The use of the sodium/glucose cotransporter 2 (SGLT-2) inhibitor dapagliflozin in patients with type 2 diabetes (T2D) and moderate renal impairment provides benefits beyond glucose lowering, with no new safety signals, in the phase III DERIVE* study.
Podcast: Professor Giuseppe Mancia talks about the role of beta-blockers in the overall treatment of hypertension
Slideshow: Highlights from the Asian Pacific Society of Cardiology Congress (APSC) 2018
The appropriate use of sodium/glucose cotransporter 2 inhibitors (SGLT2i) may prevent serious adverse events (SAEs) among Japanese patients with type 2 diabetes (T2D), according to a retrospective analysis of data from medical claim database presented at APSC 2018.
Certain antidiabetic agents (ie, insulin and thiazolidinediones) have been found to be associated with increased cancer risk; however, other studies suggested that metformin may have anticarcinogenic potential, according to a presentation at APSC 2018.
Multimedia
